Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

AstraZeneca’s baxdrostat shows promise in phase 3 hypertension study

Around 1.3 billion people globally are living with consistently high blood pressure levels

- PMLiVE

Innovative Trials names Hertfordshire hospice as 2025 UK charity partner

Innovative Trials, an internationally renowned clinical trials patient recruitment company based in the UK, has today announced Garden House Hospice Care as its UK charity partner for 2025/26. It continues...

Innovative Trials

- PMLiVE

Education urgently needed to reverse lack of women-only clinical trials

Kate Shaw, founder and CEO of Innovative Trials, has responded to data that shows the UK has far fewer women-only clinical trials compared to male-only studies. Read the full article here.

Innovative Trials

- PMLiVE

Merck to expand respiratory disease portfolio with $10bn Verona acquisition

The deal includes a drug approved in the US for chronic obstructive pulmonary disease

- PMLiVE

FDA publishes over 200 complete response letters in effort to increase transparency

The letters were issued in response to applications submitted to the regulator between 2020 and 2024

- PMLiVE

Havas to Open New Manchester Village at Circle Square

The global communications group will unite six agencies under one roof in a purpose-built, hybrid workspace at the heart of Manchester’s innovation district

Havas Lynx

- PMLiVE

Amgen’s bemarituzumab shows promise in phase 3 gastric cancer study

Almost one million new cases of gastric cancer are diagnosed globally every year

EU flag

EC approves Biocon Biologics’ denosumab biosimilars Vevzuo and Evfraxy

An estimated 32 million people aged 50 years and over in Europe were living with osteoporosis in 2019

- PMLiVE

Current market challenges are redefining the biotech landscape

Short-term uncertainty is slowing investment activity, but the long-term outlook remains strong

Maximize Conference Impact Virtually – Engaging Your Advisors Creatively

Extend the impact of scientific conferences! Discover how to creatively empower your advisors to share patient cases and evidence, sparking rich discussions on clinical implications and research questions. Drive deeper...

Impetus Digital

- PMLiVE

AstraZeneca’s Imfinzi regimen approved by EC to treat muscle-invasive bladder cancer

More than 35,000 people in five major European countries were treated for the disease last year

- PMLiVE

FDA approves Dizal’s oral therapy Zegfrovy to treat advanced lung cancer

Around 226,650 new cases of lung cancer are expected to be diagnosed in the US this year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links